Shirel Dorman-Ilan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shirel Dorman-Ilan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Asia Avinir
School of Behavioral Sciences, The Academic College of Tel-Aviv—Yaffo, Tel Aviv 6818211, Israel
1 shared publication - Doron Gothelf
Department of Child and Adolescent Psychiatry, Sheba Hospital, Ramat Gan, Israel
1 shared publication - Ehud Mekori-Domachevsky
The Child Psychiatry Division, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel
1 shared publication - Ilanit Hasson-Ohayon
Bar-Ilan University
1 shared publication - Itai M. Pessach
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
1 shared publication - Mariela Mosheva
The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel.
1 shared publication
Latest Publications
- Open Access
A 16-Month Longitudinal Investigation of Risk and Protective Factors for Mental Health Outcomes Throughout Three National Lockdowns and a Mass Vaccination Campaign: Evidence from a Weighted Israeli Sample During COVID-19
Background: The COVID-19 pandemic is an ongoing global crisis, with a multitude of factors that affect mental health worldwide. Here, we explore potential predictors for the emergence and maintenance of depression, anxiety, and posttraumatic stress symptoms (PTSS) in the general population in Israel. Methods: Across the span of 16 months, 2,478 people completed a repeated self-report survey which inquired psychiatric symptoms and pandemic related stress factors (PRSF). PRSF were divided into four clusters of environmental stressors: financial, health-related, fatigue and sense of protection by authorities. We applied mixed-effects linear models to assess how each stressor contributes to depression, anxiety and PTSS at each time point, alongside a longitudinal exploration among participants who completed at least two consecutive surveys ( n =400). Results: Fatigue was the strongest predictor for depression, anxiety and PTSS at all time points ( standardized β between 0.28-0.60, p <.0001), and predicted deterioration overtime ( β between 0.22-0.36, p <.0001). Financial concerns associated with depression and anxiety at all time points ( β between 0.13- 0.26, p <.01), and with their deterioration overtime ( β between 0.16-0.18, p <.0001), while health related concerns were uniquely associated with anxiety and PTSS at all time points ( β between 0.14-0.29, p <.01) and their deterioration ( β between 0.11-0.16, p <.001), but not with depression. Improvement in sense of protection overtime associated with decrease in depression and anxiety ( β between −0.09 to −0.16, p <.01). Conclusions: Our findings accentuate the multitude of risk factors for psychiatric morbidity during COVID-19, and the dynamics in their association with different aspects of psychopathology at various time points.
Open AccessA 16-Month Longitudinal Investigation of Risk and Protective Factors for Mental Health Outcomes Throughout Three National Lockdowns and a Mass Vaccination Campaign: Evidence from a Weighted Israeli Sample During COVID-19
Background: The COVID-19 pandemic is an ongoing global crisis, with a multitude of factors that affect mental health worldwide. Here, we explore potential predictors for the emergence and maintenance of depression, anxiety, and posttraumatic stress symptoms (PTSS) in the general population in Israel. Methods: Across the span of 16 months, 2,478 people completed a repeated self-report survey which inquired psychiatric symptoms and pandemic related stress factors (PRSF). PRSF were divided into four clusters of environmental stressors: financial, health-related, fatigue and sense of protection by authorities. We applied mixed-effects linear models to assess how each stressor contributes to depression, anxiety and PTSS at each time point, alongside a longitudinal exploration among participants who completed at least two consecutive surveys ( n =400). Results: Fatigue was the strongest predictor for depression, anxiety and PTSS at all time points ( standardized β between 0.28-0.60, p <.0001), and predicted deterioration overtime ( β between 0.22-0.36, p <.0001). Financial concerns associated with depression and anxiety at all time points ( β between 0.13- 0.26, p <.01), and with their deterioration overtime ( β between 0.16-0.18, p <.0001), while health related concerns were uniquely associated with anxiety and PTSS at all time points ( β between 0.14-0.29, p <.01) and their deterioration ( β between 0.11-0.16, p <.001), but not with depression. Improvement in sense of protection overtime associated with decrease in depression and anxiety ( β between −0.09 to −0.16, p <.01). Conclusions: Our findings accentuate the multitude of risk factors for psychiatric morbidity during COVID-19, and the dynamics in their association with different aspects of psychopathology at various time points.